Skip to content

Acute Effects of a Stretching Program of the Rib Cage Muscles on Patients With COPD During Exercise

Acute Effects of a Stretching Program of the Rib Cage Muscles on the Regional Distribution of Ventilation and the Diaphragmatic Mobility of Patients With COPD During Exercise: a Randomized Crossover Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02383277
Enrollment
20
Registered
2015-03-09
Start date
2014-11-30
Completion date
2015-11-30
Last updated
2015-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Brief summary

Investigate the effects of stretching the muscles of the rib cage in individuals with COPD during exercise.

Detailed description

To investigate the effects of a stretching program for the muscles of the rib cage or control in patients with COPD during exercise and / or the immediate post-exercise, using the following parameters: * Tidal volume (VT), respiratory rate (RR), minute volume (MV), inspiratory time (Tins) and expiratory (T exp). * Change in volumes of total and regional chest magazines (pulmonary rib cage, abdominal rib cage and abdomen). * Diaphragmatic mobility. * electrical muscle activity * endurance time. * Dyspnea sensation.

Interventions

OTHERStretching

Stretching of the rib cage muscles

OTHERControl

Rest without stretching (sham)

OTHERExercise

Constant load exercise on a bike

Sponsors

Universidade Federal de Pernambuco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Smoking history, occupational or environmental exposure to pollutants and / or symptoms of cough, dyspnea or hypersecretion; * FEV1 \<80% predicted and post-bronchodilator FEV1 / FVC \<70% to confirm the diagnosis of airway obstruction not fully reversible bronchodilator therapy; * Absence of co-morbidities that does not allow the realization of stress (hypertension, severe pulmonary hypertension, myocardial infarction, congestive heart failure, severe dyspnoea); * Preserved cognitive functioning; * Sedentary * Clinically stable during the study period.

Exclusion criteria

* Patients with cognitive, hearing or visual deficit; * Changes in the neuro-musculo-skeletal system which endangers or impairs the assessment; * Obese * Not be able to achieve at least three stages of the incremental test.

Design outcomes

Primary

MeasureTime frame
Endurance tolerance as measured by the duration of the exerciseParticipants will be followed for the duration of the exercise, an expected average of 10 minutes
Dyspnea as measured by Borg EscaleParticipants will be followed for the duration of the exercise, an expected average of 10 minutes

Secondary

MeasureTime frame
Diaphragm mobility measured by ultrasoundParticipants will be followed for the duration of the stretching and the exercise, an expected average of 60 minutes
Volumes of the chest wall measured by pletismography optoelectronicParticipants will be followed for the duration of the stretching and the exercise, an expected average of 60 minutes
Muscle electrical activity measured by surface electromyographyParticipants will be followed for the duration of the stretching and the exercise, an expected average of 60 minutes

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026